发明名称 Diphenyl heterocycles as potassium channel modulators
摘要 These compounds, which are useful to treat disorders responsive to openers of the large conductance calcium-activated potassium channels, are of formula (1): where "Het" is one of a select group of heterocyclic moieties; Z is independently for each occurrence selected from O or S; Ra, Rb and Rc each are independently selected from hydrogen, halogen, OH, CF3, NO2, or (a); provided Rc is not hydrogen; and when Ra and Rb are hydrogen, Rc may be a heterocyclic moiety selected from the group consisting of imidazol-1-yl, morpholinomethyl, N-methylimidazol-2-yl, and pyridin-2-yl; Rd and Re each are independently selected form hydrogen, halogen, CF3, NO2 or imidazol-1-yl; m, n and p each are independently selected from an integer of 0 or 1; and Rf and Rg each are independently hydrogen; C1-4 alkyl; or Rf and Rg, taken together with the nitrogen atom to which they are attached, is a heterocyclic moiety selected from the group consisting of N-methylpiperazine, morpholine, thiomorpholine, N-benzylpiperazine and imidazolinone.
申请公布号 NZ334403(A) 申请公布日期 2000.09.29
申请号 NZ19970334403 申请日期 1997.07.30
申请人 BRISTOL-MYERS SQUIBB COMPANY 发明人 ROMINE, JEFFREY L;MARTIN, SCOTT W;HEWAWASAM, PIYASENA;MEANWELL, NICHOLAS A;GRIBKOFF, VALENTIN K;STARRETT, JOHN E
分类号 C07D271/02;A61K31/4164;A61K31/4166;A61K31/4196;A61K31/4245;A61P9/10;A61P25/00;A61P25/08;A61P43/00;C07D233/32;C07D233/54;C07D233/64;C07D233/70;C07D233/74;C07D233/76;C07D235/12;C07D249/08;C07D249/12;C07D249/14;C07D263/58;C07D271/10;C07D271/113;C07D413/10;(IPC1-7):C07D233/70;A61K31/41;A61K31/415;C07D249/06;C07D233/78;C07D233/72 主分类号 C07D271/02
代理机构 代理人
主权项
地址